NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

DOMINION MINERALS LIMITED (DLM)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of DLM: rating 1
(1 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services Brisbane
Level 21, 10 Eagle Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000184202
Address: C/- Company Matters Pty Limited Level 21, 10 Eagle Street Brisbane QLD 4000
Tel:  07 3334 3900Fax: 07 3334 3999

Date first listed: 19/03/2004

Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology Research and Development

News & Events

Expand this box to read and print

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

10/07/2024

The company releases the results of its meeting.

24/05/2024

The company lodges its Quarterly Activities Report and Appendix 5B.

29/04/2024

The company lodges its Quarterly Activities Report and Appendix 5B.

29/04/2024

The AGM will be held on 24 May 2024, 10.00am (AEST), at Level G, 121 King William Street Adelaide SA 5000

24/04/2024

The Company's Annual General Meeting will be held on Friday 24 May 2024. An election of directors will be held at this AGM pursuant to ASX Listing Rule 14.5. The closing date for receipt of nominations for the position of Director is Thursday, 25 April 2024. Any nominations must be received in writing no later than 5.00pm (AEST) on 25 April 2024 at the Company's registered office.

15/04/2024

The company releases its Appendix 4G and Corporate Governance Statement.

26/03/2024

The company lodges its Annual Report to shareholders.

26/03/2024

The company lodges its Quarterly activities report and quarterly cashflow report.

30/01/2024

Regarding the option to purchase the Georgia Lime Project in south west Georgia, USA held by PowerLime Inc., this was previously extended by Dominion until 31 October 2023 while the Company evaluated a decision on whether to purchase the surface and mineral rights that comprise the Project for a purchase price of US$1.5 million. Based upon evaluation of the work undertaken to date, Dominion has assessed that current market conditions for regional agricultural lime operations in the south east U.S. are generally not favourable to support development of new lime projects of the scale required to generate significant shareholder returns. The Dominion Board has resolved to let the Option lapse unexercised. Dominion Board has resolved to let the Option lapse unexercised. Dominion has been presented with a number of potential alternate business acquisition opportunities, with a focus on projects in the critical minerals sector, and is in advanced negotiations for a potential corporate acquisition.

03/11/2023

The company lodges its Quarterly Activities Report and Quarterly Cashflow Report.

31/10/2023

The company releases a notice of application for quotation of securities.

31/10/2023

The following securities will be released from ASX imposed escrow at 4.00pm (AEDT) on 31 October 2023: 18,750,000 fully paid ordinary shares; and 16,187,498 unlisted options. Dominion will apply for quotation of the 18,750,000 fully paid ordinary shares on Tuesday 30 October 2023.

25/10/2023

Dominion is not yet in a position to make an announcement in relation to the potential corporate acquisition. Dominion requests that the voluntary suspension remains in place until the Company makes an announcement to the market in relation to the corporate acquisition.

09/10/2023

Dominion requests that the voluntary suspension remains in place until the earlier of the Company making announcement to the market in relation to the corporate acquisition or the commencement of trading on Monday 9 October 2023.

25/09/2023

The company lodges its Half Year Accounts.

13/09/2023

Dominion requests that the voluntary suspension remains in place until the earlier of the Company making announcement to the market in relation to the corporate acquisition or the commencement of trading on Monday 25 September 2023.

11/09/2023

The company is providing an update on the option to purchase the Georgia Lime Project in south west Georgia USA held by the company's 100% owned U.S. subsidiarym PowerLime, Inc. The company has secured an extension to the option until 31 October 2023 in exchange for US$5,000. Dominion is in the process of assessing a potential corporate acquisition not associated wtih the Georgia Lime Project. The company's securities will remain suspended pending an announcement in relation to the alternate potential corporate acquisition.

01/09/2023

The securities of Dominion Minerals Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of DLM, pending the release of an announcement regarding an option to acquire land on which the Georgia Lime Project is located and a potential corporation acquisition.

31/08/2023

The suspension of trading in the securities of Dominion Minerals Limited (formerly Factor Therapeutics Limited) will be lifted from the commencement of trading on Monday, 1 November 2021 following its recompliance with Chapters 1 and 2 of the ASX Listing Rules.

29/10/2021

The company releases the following: Appendix 1A, Information Form and Checklist, Constitution, Distribution Schedule, Information Form and Checklist Annexure 1, Powerlime Audited Accounts 31 December 2020, Powerlime Half Year Accounts 30 June 2021, Securities Trading Policy, Statement of Confirmations and Top 20 holders.

29/10/2021

Description It is anticipated that the securities of Dominion Minerals Limited will be reinstated to quotation at 10:02:15 (+/- 15 seconds) AEDT on Monday, 1 November 2021, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules. DLM raised $4,000,000 pursuant to the offer under its replacement prospectus dated 9 September 2021 by the issue of 100,000,000 shares at an issue price of $0.04 per share.

29/10/2021

name changed from Factor Therapeutics Limited

29/10/2021

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    17/06/2014Iain Ross66,000$0.290$19,140
    04/03/2014Melvyn Bridges28,000$0.350$9,800
    03/03/2014Melvyn Bridges99,800$0.304$30,379
    02/12/2011Melvyn Bridges97,988$0.415$40,665
    30/11/2011Melvyn Bridges53,661$0.415$22,269

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David BrookesChairman10/04/2019
    Stephen KellyCFO, Company Secretary08/10/2021
    Dominic AllenNon Exec Director03/11/2021
    Taso ArimaNon Exec Director03/11/2021

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    John MichailidisNon Exec Director14/02/201703/11/2021
    Melanie FarrisNon Exec Director, Company Secretary20/04/202103/11/2021
    Christian BehrenbruchNon Exec Director12/10/201528/05/2021
    Cherrell HirstChairman30/06/200930/07/2020
    Timothy HughesNon Exec Director03/11/201415/05/2019
    Rosalind WilsonCEO19/06/201725/01/2019
    Robert P. RyanNon Exec Director13/09/201612/12/2018
    Nigel JohnsonCOO07/04/201516/06/2017
    Melvyn BridgesNon Exec Director12/03/200925/11/2015
    Iain RossNon Exec Director25/05/201217/09/2015
    Drummond McKenzieCFO05/09/201112/08/2015
    Roger ClarkeChairman06/11/200331/05/2015
    Steven MercerDirector, CEO13/09/200407/04/2015
    Greg BayntonDirector31/12/200812/06/2012
    Donald HomeNon Exec Director25/01/2009
    Neil ReinhardtNon Exec Director16/11/2006

    Date of first appointment, title may have changed.